Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Provision of a Manufacturing Execution System (MES) tailored explicitly for the field of cell therapies, The MES platform should enable resource scheduling, inventory optimisation, management & execution of electronic batch records and overall manufacturing workflows, review and release activities. All workflows should be client-configurable and controlled, through the use of a zero-code, platform-embedded, builder configuration tool. The platform should be designed to comply with US FDA, EU EMA & UK MHRA guidance and aligns with the GAMP5 validation methodology, as well as being CFR 21 Part 11 compliant.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Autolomous Ltd | 11810723 | - | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £350,000 initial term | 1 single bid — no competition | Autolomous Ltd | active |
Weightings from the notice.